468 related articles for article (PubMed ID: 19441927)
1. RNA interference as an anticancer therapy: a patent perspective.
Dykxhoorn DM
Expert Opin Ther Pat; 2009 Apr; 19(4):475-91. PubMed ID: 19441927
[TBL] [Abstract][Full Text] [Related]
2. Advances in cell-type specific delivery of RNAi-based therapeutics.
Dykxhoorn DM
IDrugs; 2010 May; 13(5):325-31. PubMed ID: 20432190
[TBL] [Abstract][Full Text] [Related]
3. RNA interference in cancer.
Gartel AL; Kandel ES
Biomol Eng; 2006 Mar; 23(1):17-34. PubMed ID: 16466964
[TBL] [Abstract][Full Text] [Related]
4. Short interfering RNA (siRNA): tool or therapeutic?
Cejka D; Losert D; Wacheck V
Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
6. Review article: RNA interference--potential therapeutic applications for the gastroenterologist.
Pellish RS; Nasir A; Ramratnam B; Moss SF
Aliment Pharmacol Ther; 2008 May; 27(9):715-23. PubMed ID: 18248657
[TBL] [Abstract][Full Text] [Related]
7. RNA interference and potential therapeutic applications of short interfering RNAs.
Karagiannis TC; El-Osta A
Cancer Gene Ther; 2005 Oct; 12(10):787-95. PubMed ID: 15891770
[TBL] [Abstract][Full Text] [Related]
8. RNA interference: potential therapeutic targets.
Jana S; Chakraborty C; Nandi S; Deb JK
Appl Microbiol Biotechnol; 2004 Nov; 65(6):649-57. PubMed ID: 15372214
[TBL] [Abstract][Full Text] [Related]
9. Prospects of RNA interference therapy for cancer.
Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
[TBL] [Abstract][Full Text] [Related]
10. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
11. siRNA-based approaches in cancer therapy.
Devi GR
Cancer Gene Ther; 2006 Sep; 13(9):819-29. PubMed ID: 16424918
[TBL] [Abstract][Full Text] [Related]
12. RNA interference: new mechanisms for targeted treatment?
Woessmann W; Damm-Welk C; Fuchs U; Borkhardt A
Rev Clin Exp Hematol; 2003 Sep; 7(3):270-91. PubMed ID: 15024970
[TBL] [Abstract][Full Text] [Related]
13. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleic acid interference for neurological disorders: candidate diseases, potential targets, and current approaches.
Federici T; Boulis NM
Neurosurgery; 2007 Jan; 60(1):3-15; discussion 15-6. PubMed ID: 17228249
[TBL] [Abstract][Full Text] [Related]
15. RNA interference for therapy in the vascular endothelium.
Kaufmann J; Ahrens K; Santel A
Microvasc Res; 2010 Sep; 80(2):286-93. PubMed ID: 20144624
[TBL] [Abstract][Full Text] [Related]
16. [RNA interference and molecular pathology of selected diseases].
Lochmanová J; Bartos M
Cas Lek Cesk; 2008; 147(12):607-15. PubMed ID: 19235485
[TBL] [Abstract][Full Text] [Related]
17. Small silencing RNAs: state-of-the-art.
Grimm D
Adv Drug Deliv Rev; 2009 Jul; 61(9):672-703. PubMed ID: 19427885
[TBL] [Abstract][Full Text] [Related]
18. RNAi: a novel antisense technology and its therapeutic potential.
Dallas A; Vlassov AV
Med Sci Monit; 2006 Apr; 12(4):RA67-74. PubMed ID: 16572063
[TBL] [Abstract][Full Text] [Related]
19. Why RNAi makes sense.
Hough SR; Wiederholt KA; Burrier AC; Woolf TM; Taylor MF
Nat Biotechnol; 2003 Jul; 21(7):731-2. PubMed ID: 12833082
[No Abstract] [Full Text] [Related]
20. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
